Compugen (Israeli company)

http://dbpedia.org/resource/Compugen_(Israeli_company) an entity of type: Thing

Compugen Ltd. (Hebrew: קומפיוג'ן) is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big pharmas such as Novartis AG, Abbot Laboratories and Pfizer Inc. Subsequently, Compugen made a decision to become a drug development company with its own internal pipeline, and in 2010, decided to a focus on oncology and immunology. OncoMed Pharmaceuticals and are among Compugen's competi rdf:langString
rdf:langString Compugen (Israeli company)
rdf:langString Compugen Ltd.
rdf:langString Compugen
rdf:langString Compugen Ltd.
xsd:integer 1119774
xsd:integer 34046261
xsd:integer 1110509234
rdf:langString Amir Natan
rdf:langString Eli Mintz
rdf:langString Simchon Faigler
rdf:langString
rdf:langString Paul Sekhri
rdf:langString Compugen logo.gif
rdf:langString US$ -8.5 million ()
rdf:langString US$ -8.7 million ()
rdf:langString US$ 53 thousand ()
rdf:langString CGEN
rdf:langString NASDAQ:CGEN
rdf:langString Compugen Ltd. (Hebrew: קומפיוג'ן) is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big pharmas such as Novartis AG, Abbot Laboratories and Pfizer Inc. Subsequently, Compugen made a decision to become a drug development company with its own internal pipeline, and in 2010, decided to a focus on oncology and immunology. OncoMed Pharmaceuticals and are among Compugen's competitors.
xsd:nonNegativeInteger 18324
xsd:gYear 1993
<usDollar> -8500000.0
<usDollar> -8700000.0
<usDollar> 53000.0

data from the linked data cloud